A New Anti-triple Negative Breast Cancer Agent
A unique heat-labile enterotoxin cytotoxic to triple-negative breast cancer (TNBC) cells with reduced side effects.
Background:
Approximately 10-15% of all breast cancers are triple negative, lacking the estrogen or progesterone receptors and the human epidermal growth factor receptor 2 (HER2). TNBC is an aggressive form of cancer with a poorer...
Published: 3/19/2025
|
Inventor(s): Terry Connell, Natalie King-Lyons, Hesham Nawar
Keywords(s): Featured, Technologies, Therapeutic and Vaccines
Category(s): Campus > University at Buffalo, Technology Classifications > Therapeutics and Vaccines
|